Avadel Pharmaceuticals (AVDL) Stock Price, News, Quotes-Moomoo

US Stock MarketDetailed Quotes

AVDL Avadel Pharmaceuticals

Watchlist

11.660
0.0000.00%

Close Nov 22 16:00 ET

1.12BMarket Cap-15546P/E (TTM)

Pre-Market

5D
Daily
Weekly
Monthly
1Q
1Y

Trade Overview

Unit: --

Capital Trend

IntradayDayWeekMonth

No Data

News

UBS Maintains Avadel Pharmaceuticals(AVDL.US) With Buy Rating, Cuts Target Price to $22
Moomoo NewsNov 19 13:31 ET · Ratings
US Manufacturing Index Rises To 43, Highest Since 2020
Business TodayNov 16 02:13 ET
Avadel Pharmaceuticals to Present at the Jefferies London Healthcare Conference
GlobeNewswireNov 13 08:00 ET
H.C. Wainwright Maintains Avadel Pharmaceuticals(AVDL.US) With Buy Rating, Cuts Target Price to $25
Moomoo NewsNov 13 06:31 ET · Ratings
Express News | Avadel Pharmaceuticals PLC : Piper Sandler Raises Target Price to $24 From $23
ReutersNov 12 23:56 ET
Avadel Pharmaceuticals Reports Strong Growth With LUMRYZ
TipRanksNov 12 23:05 ET

Comments

Stock_Drift

Oct 31 12:19

Unusual Volume Ticks. 1:18pm 🎃

$Roblox (RBLX.US)$ $Anavex Life Sciences (AVXL.US)$ $Santech Holdings (STEC.US)$ $Lead Real Estate (LRE.US)$ $Avadel Pharmaceuticals (AVDL.US)$ $Carvana (CVNA.US)$ $Lemonade (LMND.US)$ $Autonomix Medical (AMIX.US)$ $Peloton Interactive (PTON.US)$ $PLBY Group (PLBY.US)$ $Alphatec (ATEC.US)$ $Universal Security Instruments (UUU.US)$ $Biofrontera (BFRI.US)$ $Root Inc (ROOT.US)$
🎃⚡️🎃

Bigmoney Dreamer

Oct 31 12:16

$Avadel Pharmaceuticals (AVDL.US)$
Given its current financial standing and market movements, Avadel Pharmaceuticals is assessed as a moderately high-risk investment. The company's unprofitability, negative cash flow, and strong dependency on news-related catalysts pose potential risks. Nonetheless, the recently improved stock sentiment, coupled with analysts' positive forecasts, suggests some upside potential. The relatively high position in its volatility scale underscores the need for caution,...

Jaguar8

Oct 30 18:29

Hey 👋

$Avadel Pharmaceuticals (AVDL.US)$

Trytosaveabit

Oct 17 08:47

News

$Avadel Pharmaceuticals (AVDL.US)$ Reuters
4 mins ago
Avadel Pharmaceuticals Announces FDA Approval of Lumryz™ (Sodium Oxybate) Extended-Release Oral Suspension (Ciii) for the Treatment of Cataplexy or Excessive Daytime Sleepiness in Patients 7 Years of Age and Older With Narcolepsy

Analyst Rating

No Data

Price Target

No Data

Heat List

Overall

No Data

AVDL Avadel Pharmaceuticals

Trade Overview

Capital Trend

News

Comments

Analysis

Analyst Rating

Price Target